MAPT and Alzheimer disease: In mouse models, circadian rhythm disruption through the overexpression of human P301L tau led to increased wakefulness and decreased nonrapid eye movement (NREM) and REM sleep episodes,54 paralleling circadian rhythm disruptions observed in Alzheimer's disease (AD) patients with tau deposits.